/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

V

Vanessa A. Fabrizio

Center for Cancer and Blood Disorders(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

70

Papers

610

Citations

12

h-index

12

i10-index

Vanessa A. Fabrizio is an academic researcher from Center for Cancer and Blood Disorders. The author has contributed to research in topics: CAR-T cell therapy research & Acute Lymphoblastic Leukemia research & Hematopoietic Stem Cell Transplantation. The author has an h-index of 12, co-authored 60 publications.

ORCID: 0000-0002-8405-1141

Research Topics

CAR-T cell therapy research Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation Virus-based gene therapy research Childhood Cancer Survivors' Quality of Life

Papers by this author

works

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

2021 · Blood Advances · 103 citations

https://doi.org/10.1182/bloodadvances.2021006418

Vanessa A. Fabrizio Jaap Jan Boelens Audrey Mauguen Christina Baggott

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

2022 · Journal of Clinical Oncology · 72 citations

https://doi.org/10.1200/jco.22.01076

Liora M. Schultz Anne Eaton Christina Baggott Jenna Rossoff

ALL-173 Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results

2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations

https://doi.org/10.1016/s2152-2650(24)01093-0

Rayne H. Rouce Susanne H.C. Baumeister Kevin J. Curran Vanessa A. Fabrizio

Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results

2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations

https://doi.org/10.1016/s2152-2650(24)00413-0

Rayne H. Rouce Susanne H.C. Baumeister Kevin J. Curran Vanessa A. Fabrizio

Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results

2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations

https://doi.org/10.1016/s2152-2650(24)00386-0

Rayne H. Rouce Susanne H.C. Baumeister Kevin J. Curran Vanessa A. Fabrizio

Research topics

topics

CAR-T cell therapy research

Acute Lymphoblastic Leukemia research

Hematopoietic Stem Cell Transplantation

Virus-based gene therapy research

Childhood Cancer Survivors' Quality of Life

Chat about Author

Papers

Chat

Click to start Chat